Status
Conditions
About
The purpose of this study is to evaluate the effectiveness of fluorometholone combined with sodium hyaluronate eye drops in the treatment of Sjögren syndrome.
Enrollment
Sex
Ages
Volunteers
Inclusion and exclusion criteria
Inclusion Criteria:
willing to participate in this clinical study, and signed informed consent
age from 18 to 70 years old,both genders are permitted
diagnosed as the Sjögren syndrome
have the symptoms and signs of dry eye disease as below:
have at least 2 symptoms such as dryness,foreign body sensation ,eye strain,conjunctival congestion,secretion.The summed up score of symptoms greater than 6.
the score of tear-film break up time less than 5 seconds or the score of Schirmer test less than 5mm/5min.
the score of corneal fluorescein staining greater than 3.
Exclusion Criteria:
35 participants in 2 patient groups
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal